Screener
Prime Medicine PRME Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands) | June 30,2026 | December 31,2025 |
|---|---|---|
| Accrued expenses and other current liabilities | ||
| Employee compensation and benefits | $3,415 | $7,337 |
| License fee | 3,312 | 1,562 |
| Research and clinical costs | 1,335 | 1,997 |
| Other | 916 | 1,704 |
| Total accrued expenses and other current liabilities | $8,978 | $12,600 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's accrued expenses?
- Prime Medicine (PRME) reported accrued expenses of $3.42M in Q2 2026.
- How has Prime Medicine's accrued expenses changed year-over-year?
- Prime Medicine's accrued expenses decreased by 41.3% year-over-year, from $5.82M to $3.42M.
- What is the long-term trend for Prime Medicine's accrued expenses?
- Over 4 years (2021 to 2025), Prime Medicine's accrued expenses has grown at a -33.4% compound annual growth rate (CAGR), from $37.19M to $7.34M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Prime Medicine's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude